Bisphosphonate를 복용하는 환자에게 임프란트 치료시 고려사항
Considerations during dental implant treatment for patients under bisphosphonate therapy
박원서, 정원윤, 김형준, 김기덕,
소속 상세정보
박원서 ( Park Won-Se ) - 연세대학교 치과대학병원 통합진료과
정원윤 ( Chung Won-Yoon ) - 연세대학교 치과대학 구강생물학교실
김형준 ( Kim Hyung-Jun ) - 연세대학교 치과대학 구강악안면외과학교실
김기덕 ( Kim Kee-Deog ) - 연세대학교 치과대학병원 통합진료과
KMID : 0362720110490070389
Abstract
Bisphosphonate inhibits the function of osteoclast, so they are widely used for multiple myeloma, Paget? disease, metastatic malignant bone disease, and severe osteoporosis. This drug is very effective for preventing severe complication of osteoporosis, some unpredictable complication occurred such as esophageal malignancy, atypical fracture of femur, and osteonecrosis of the jaw. Bisphosphonate related osteonecrosis of the jaw (BRONJ) is closely related with invasive, open bone surgery like tooth extraction. BRONJ associated with dental implant is rare, however, as the use of bisphosphonate increase, BRONJ cases with dental implant are increasing. In this article, we will describe the considerations during dental implant treatment for patient under bisphosphonate therapy.
키워드
Bisphosphonate; implant; dental considerations
원문 및 링크아웃 정보
등재저널 정보